Advanced Diffusion Imaging in Renal Cancer Patients

Running, not enrolling · Not applicable

Conditions studied: Renal Cancer

In brief

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

Key facts

Study ID

NCT06116253

Run by

NYU Langone Health

People needed

39

Starts

2022-12-01

Expected to finish

2028-12-01

Last updated by the study team

2026-05-08

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Renal mass patients scheduled for laparoscopic partial nephrectomy.
• eGFR above 30 ml/min/m2.
• Ages 21 to 85
• Must be willing and able to provide consent.

You may not qualify if…

• All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.
• Pregnant women are not eligible for participating in this study.
• Acute claustrophobia

Where it is running

• NYU Langone Health — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.